VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMRXAmneal Pharmaceuticals, Inc.
$17.23$5.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAMRXQuarterly Balance Sheet

Amneal Pharmaceuticals, Inc. (AMRX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Amneal Pharmaceuticals, Inc. (AMRX) quarterly balance sheet — complete assets, liabilities & equity history

AMRX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Total Current Assets1.8B1.91B1.84B1.58B1.51B1.59B1.51B1.49B1.38B1.38B1.46B1.42B
Cash & Short-Term Investments197.66M310.87M201.25M81.19M59.19M112.42M74.01M47.22M48.45M93.74M92.05M112.64M
Cash Only197.66M310.87M201.25M81.19M59.19M110.55M74.01M43.77M48.45M91.54M86.93M109.28M
Short-Term Investments000001.87M03.45M02.2M5.12M3.36M
Accounts Receivable902.65M939.87M924.14M849.26M800.29M775.73M786.23M803.38M704.05M645.66M690.95M674.74M
Days Sales Outstanding114.76105.3103.98103.59101.9898.36104.0997.7393.1699.65101.3292.7
Inventory641.62M606.3M614.5M608.97M601.43M612.45M596.36M575.62M570.65M581.38M576.47M550.56M
Days Inventory Outstanding139.55108.59110.24125.67124.28118.91124.53115.43124.47136.04133.79129.6
Other Current Assets4.17M4.44M34.73M3.74M9.02M40.7M4.34M2.41M5.1M7.57M48.89M44.3M
Total Non-Current Assets1.74B1.77B1.76B1.84B1.85B1.91B1.95B2.02B2.08B2.09B2.23B2.28B
Property, Plant & Equipment558.76M550.33M538.05M546.29M522.75M523.69M532.9M528.94M544.78M550.14M560.8M571.27M
Fixed Asset Turnover1.30x1.50x1.45x1.36x1.33x1.38x1.32x1.31x1.20x1.11x1.10x1.04x
Goodwill593.8M595.47M595.95M597.41M597.5M597.44M598.32M598.53M598.55M598.63M598.63M599.21M
Intangible Assets534.87M563.5M587.94M649.55M689.14M732.38M780.19M819.94M859.27M890.42M982.53M1.02B
Long-Term Investments12.73M7.82M018.92M26.39M35.92M17.94M52.46M52.63M37.09M74.34M79.63M
Other Non-Current Assets42.15M49.98M39.46M25.93M19.03M24.21M18.34M24.57M21.11M18.43M14.71M13.61M
Total Assets3.54B3.68B3.6B3.42B3.37B3.5B3.46B3.51B3.46B3.47B3.69B3.7B
Asset Turnover0.20x0.22x0.22x0.21x0.20x0.21x0.20x0.20x0.19x0.17x0.17x0.16x
Asset Growth %5.2%5.05%4.01%-2.48%-2.64%0.83%-6.13%-5.16%-4.69%-8.6%-4.83%-8.43%
Total Current Liabilities728.05M881.63M862.11M1.11B1.08B1.13B1.1B1.11B834.39M846.6M760.6M777.35M
Accounts Payable227.68M254.67M266.36M666.82M192.53M259.84M235M199.58M175.32M143.57M177.4M139.53M
Days Payables Outstanding53.9446.3584.0889.2246.3248.6846.1837.7534.4537.7137.6233.19
Short-Term Debt6.2M21.58M7.2M321.18M321.79M324.21M364.69M435.52M212.66M213.13M106.53M150.41M
Deferred Revenue (Current)00000000400.27M398.41M00
Other Current Liabilities64.82M525.5M104.5M104.91M85.1M222.36M198.08M194.76M-14.68M3.91M220.01M240.77M
Current Ratio2.47x2.17x2.13x1.43x1.40x1.41x1.38x1.33x1.65x1.63x1.91x1.83x
Quick Ratio1.59x1.48x1.42x0.88x0.84x0.86x0.84x0.82x0.97x0.94x1.16x1.12x
Cash Conversion Cycle200.37167.54130.14140.04179.95168.58182.45175.41183.18197.98197.48189.12
Total Non-Current Liabilities2.86B2.79B2.85B2.36B2.35B2.42B2.4B2.4B2.64B2.56B2.74B2.74B
Long-Term Debt2.57B2.61B2.57B2.15B2.15B2.16B2.17B2.18B2.42B2.43B2.58B2.59B
Capital Lease Obligations109.44M102.36M97.75M100.08M87.98M91.09M94.03M95.92M97.56M95.45M99.36M102.52M
Deferred Tax Liabilities000000000000
Other Non-Current Liabilities168.47M75.79M183.47M115.9M106.86M163.33M135.81M126.14M121.45M41.77M52.92M48.41M
Total Liabilities3.59B3.67B3.71B3.47B3.42B3.55B3.49B3.51B3.47B3.41B3.5B3.52B
Total Debt2.7B2.74B2.69B2.58B2.58B2.59B2.64B2.73B2.75B2.75B2.8B2.86B
Net Debt2.5B2.43B2.48B2.5B2.52B2.48B2.57B2.68B2.7B2.66B2.72B2.75B
Debt / Equity-458.91x-------44.87x14.66x15.63x
Debt / EBITDA15.26x16.71x49.78x15.06x16.07x18.27x17.90x18.04x61.32x38.67x21.11x20.84x
Net Debt / EBITDA14.14x14.81x46.05x14.58x15.70x17.49x17.40x17.75x60.23x37.38x20.46x20.04x
Interest Coverage2.50x1.98x0.92x1.79x1.66x0.75x1.24x1.31x-0.15x-0.40x1.45x1.58x
Total Equity-45.97M5.96M-109.95M-46.73M-59.39M-44.54M-33.68M-4.07M-16.61M61.3M191.38M182.87M
Equity Growth %22.6%113.39%-226.47%-1049.03%-257.61%-172.65%-117.6%-102.22%-110.24%-70.66%-11.67%-4.19%
Book Value per Share-0.140.02-0.34-0.14-0.18-0.14-0.11-0.01-0.050.251.201.18
Total Shareholders' Equity-45.41M-70.79M-109.46M-112.53M-131.67M-109.27M-93.43M-57.47M-63.72M19.78M330.86M318.17M
Common Stock3.19M3.15M3.14M3.14M3.13M3.1M3.1M3.1M3.09M3.07M3.06M3.06M
Retained Earnings-472.75M-535M-570.08M-572.45M-594.87M-607.06M-575.98M-575.83M-581.82M-490.18M-391.53M-401.21M
Treasury Stock000000000000
Accumulated OCI-112.15M-110.73M-105.88M-97.43M-85.74M-65.51M-73.78M-30.44M-23.71M-32.35M3.87M8.08M
Minority Interest-558K76.76M-497K65.8M72.28M64.73M59.75M53.4M47.12M41.52M-139.48M-135.29M